Merck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir),...
Read more
Novartis announced that the EC approved Tasigna® (nilotinib) for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic...
Read more
AstraZeneca announced that the US FDA has approved a new indication for Faslodex (fulvestrant), expanding the indication to include use...
Read moreBayer AG and its development partner Janssen Research & Development, LLC advise that the U.S. Food and Drug Administration (FDA)...
Read more
Eagle Pharmaceuticals, Inc. announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s...
Read moreSun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has received final approval from US FDA for...
Read moreAbbVie , a research and development based global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc.announced that the U.S. FDA...
Read more
Impax Laboratories, Inc., a specialty pharmaceutical company, announced it has received final U.S. FDA approval on its ANDA for a...
Read more
NeuroRx, a clinical stage biopharma company developing the first oral therapy for Acute Suicidal Ideation and Behavior (ASIB), has been granted...
Read more
Adamas Pharmaceuticals, Inc. announced that the U.S. FDA has approved GOCOVRI extended release capsules (previously ADS-5102) for treatment of dyskinesia...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
